Synjardy 500 mg/1 (Empagliflozin and Metformin Hydrochloride TABLET) 500 mg/1

Synjardy 500 mg/1 tablets combine empagliflozin and metformin hydrochloride for managing type 2 diabetes. This oral medication supports blood sugar control as part of a comprehensive treatment plan.

Strength

500 mg/1

Pack Size

180 TABLET in 1 BOTTLE (0597-0159-18)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Synjardy 500 mg/1 tablets are designed to help manage type 2 diabetes by improving blood sugar levels. This combination medication works by increasing insulin sensitivity and reducing glucose absorption in the kidneys. It is typically used alongside diet and exercise to achieve better glycemic control.

Side Effects

Common effects of Synjardy 500 mg/1 tablets may include urinary tract infections, nausea, and diarrhea. Some users might experience dizziness or headache. These effects vary and are not experienced by everyone.

Precautions & Warnings

Synjardy 500 mg/1 tablets should be used with caution in individuals with kidney issues or a history of lactic acidosis. It is important to stay hydrated and monitor blood sugar levels regularly. Consult a healthcare provider before use.

Avoid Interactions

Synjardy 500 mg/1 tablets may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol and some over-the-counter medications can also affect its efficacy. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Synjardy 500 mg/1 tablets are used to manage type 2 diabetes by improving blood sugar control.

Store Synjardy 500 mg/1 tablets at room temperature, away from moisture and heat.

Common side effects may include urinary tract infections, nausea, and diarrhea.

Synjardy 500 mg/1 may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Synjardy 500 mg/1 is not suitable for everyone, especially those with kidney issues or a history of lactic acidosis.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.